Characterization of the binding site for inhibitors of the HPV11 E1-E2 protein interaction on the E2 Transactivation domain by photoaffinity labeling and mass spectrometry

被引:21
作者
Davidson, W
McGibbon, GA
White, PW
Yoakim, C
Hopkins, JL
Guse, I
Hambly, DM
Frego, L
Ogilvie, WW
Lavallée, P
Archambault, J
机构
[1] Boehringer Ingelheim Canada Ltd, Res & Dev, Laval, PQ H7S 2G5, Canada
[2] Boehringer Ingelheim Pharmaceut Inc, Ctr Res & Dev, Ridgefield, CT 06877 USA
关键词
D O I
10.1021/ac035335o
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
An indandione-containing class of inhibitors abrogates DNA replication of human papillomavirus (HPV) types 6 and 11 by binding reversibly to the transactivation domain (TAD) of the viral E2 protein and inhibiting its interaction with the viral El helicase. To locate the binding site of this class of protein-protein interaction inhibitors, a benzophenone derivative was used to generate an irreversibly labeled E2-TAD polypeptide. The single site of covalent modification of the E2-TAD was identified by proteolytic digestions using trypsin, LysC, and V8 proteases and characterization of the resulting peptides by LC-MS procedures. Through this methodology, the benzophenone attachment point was located at the terminal methyl of residue Met101. Evidence further pinpointed the site of photoaffinity attachment to the terminal carbon atom, which is significant in providing a definitive example of the ability to locate photoinduced cross-linking to a polypeptide with atomic resolution using solely mass spectrometric detection. The location of the inhibitor binding site vis-a-vis the Glu39 and Glu100 residues sensitive to mutation for HPV 11 E2-TAD is discussed in relation to the crystal structure of the E2-TAD from the related HPV type 16.
引用
收藏
页码:2095 / 2102
页数:8
相关论文
共 31 条
  • [11] BENZOPHENONE PHOTOPHORES IN BIOCHEMISTRY
    DORMAN, G
    PRESTWICH, GD
    [J]. BIOCHEMISTRY, 1994, 33 (19) : 5661 - 5673
  • [12] Application of micro-electrospray liquid chromatography techniques to FT-ICR MS to enable high-sensitivity biological analysis
    Emmett, MR
    White, FM
    Hendrickson, CL
    Shi, SDH
    Marshall, AG
    [J]. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 1998, 9 (04) : 333 - 340
  • [13] FLEMING SA, 1995, TETRAHEDRON, V51, P12479
  • [14] Crystal structure of the human papillomavirus type 18 E2 activation domain
    Harris, SF
    Botchan, MR
    [J]. SCIENCE, 1999, 284 (5420) : 1673 - 1677
  • [15] HATANAKA Y, 2002, CURR TOP MED CHEM, V2, P272
  • [16] HOWLEY PM, 1996, FIELDS VIROLOGY, P2045
  • [17] Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary technologies: Evidence for the allosteric inhibition of a protein-protein interaction
    Last-Barney, K
    Davidson, W
    Cardozo, M
    Frye, LL
    Grygon, CA
    Hopkins, JL
    Jeanfavre, DD
    Pav, S
    Qian, CG
    Stevenson, JM
    Tong, L
    Zindell, R
    Kelly, TA
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (24) : 5643 - 5650
  • [18] Further definition of the substance P (SP)/neurokinin-1 receptor complex -: MET-174 is the site of photoinsertion of p-benzoylhenylalanine SP
    Li, HZ
    Macdonald, DM
    Hronowski, XP
    Costello, CE
    Leeman, SE
    Boyd, ND
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) : 10589 - 10593
  • [19] Subfemtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI Fourier transform ion cyclotron resonance mass spectrometry
    Martin, SE
    Shabanowitz, J
    Hunt, DF
    Marto, JA
    [J]. ANALYTICAL CHEMISTRY, 2000, 72 (18) : 4266 - 4274
  • [20] Molecular targets for human papillomaviruses: prospects for antiviral therapy
    Phelps, WC
    Barnes, JA
    Lobe, DC
    [J]. ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1998, 9 (05) : 359 - 377